OCGN Ocugen, Inc.
Healthcare · Biological Products, (No Diagnostic Substances) · Market cap: $280.7M
–
Bought and sold by quarter, last 5 years
Open-market purchases and sales by this company's insiders, in dollars, last 5 years
| Quarter | Bought | Sold |
|---|---|---|
| 2022-Q1 | $0 | $584.0K |
| 2022-Q2 | $0 | $261.2K |
| 2022-Q3 | $0 | $549.5K |
| 2022-Q4 | $0 | $311.2K |
| 2023-Q1 | $0 | $236.0K |
| 2023-Q2 | $100.1K | $0 |
| 2023-Q3 | $0 | $0 |
| 2023-Q4 | $0 | $0 |
| 2024-Q1 | $0 | $0 |
| 2024-Q2 | $0 | $0 |
| 2024-Q3 | $0 | $0 |
| 2024-Q4 | $31.8K | $0 |
| 2025-Q1 | $0 | $0 |
| 2025-Q2 | $0 | $0 |
| 2025-Q3 | $0 | $0 |
| 2025-Q4 | $0 | $0 |
| 2026-Q1 | $0 | $0 |
| 2026-Q2 | $25.8K | $0 |
| 2026-Q3 | $0 | $589.1K |
| 2026-Q4 | $0 | $499.7K |
Bought$157.8K4 buy days
Sold$4.6M17 sell days
Net insider flow-$4.4Mnet selling · 5 years
Latest trade2026-10-09Musunuri Shankar
| Date | Side | Insider | Role | Shares | Avg price | Value | Trades |
|---|---|---|---|---|---|---|---|
| 2026-10-09 | Sell | Musunuri Shankar | CEO | 525,991 | $0.95 | $499.7K | 2 |
| 2026-09-09 | Sell | Musunuri Shankar | CEO | 525,991 | $1.12 | $589.1K | 2 |
| 2026-06-15 | Buy | Johnson-Greene Treerita Essalima | CFO | 21,000 | $1.23 | $25.8K | 1 |
| 2024-11-26 | Buy | Fernandes Prabhavathi | Director | 10,000 | $0.91 | $9.1K | 1 |
| 2024-11-22 | Buy | Castillo Kirsten | Director | 25,000 | $0.91 | $22.8K | 1 |
| 2023-06-14 | Buy | Zhang Junge | Director | 200,278 | $0.50 | $100.1K | 1 |
| 2023-02-16 | Sell | Musunuri Shankar | CEO | 100,000 | $1.08 | $108.0K | 1 |
| 2023-01-17 | Sell | Musunuri Shankar | CEO | 100,000 | $1.28 | $128.0K | 1 |
| 2022-12-16 | Sell | Musunuri Shankar | CEO | 95,809 | $1.43 | $137.0K | 1 |
| 2022-10-14 | Sell | Musunuri Shankar | CEO | 100,000 | $1.66 | $166.0K | 1 |
| 2022-10-06 | Sell | Kumar Ramesh | Director | 4,500 | $1.83 | $8.2K | 1 |
| 2022-08-11 | Sell | Castillo Kirsten | Director | 42,000 | $2.91 | $122.2K | 1 |
| 2022-07-18 | Sell | Kumar Ramesh | Director | 7,500 | $2.57 | $19.3K | 1 |
| 2022-07-14 | Sell | Musunuri Shankar | CEO | 150,000 | $2.72 | $408.0K | 1 |
| 2022-05-13 | Sell | Musunuri Shankar | CEO | 125,000 | $1.92 | $240.0K | 1 |
| 2022-04-18 | Sell | Kumar Ramesh | Director | 7,500 | $2.83 | $21.2K | 1 |
| 2022-03-16 | Sell | Musunuri Shankar | CEO | 81,823 | $2.65 | $216.8K | 1 |
| 2022-02-14 | Sell | Musunuri Shankar | CEO | 90,000 | $3.74 | $336.6K | 1 |
| 2022-01-18 | Sell | Kumar Ramesh | Director | 7,500 | $4.07 | $30.5K | 1 |
| 2021-12-16 | Sell | Musunuri Shankar | CEO | 115,000 | $5.22 | $600.3K | 1 |
| 2021-11-16 | Sell | Musunuri Shankar | CEO | 115,000 | $8.04 | $924.6K | 1 |
Who the insiders are, last 5 years
Everyone who bought or sold this company's shares on the open market in the last 5 years, biggest first.
| Insider | Role | Bought | Sold | Last trade |
|---|---|---|---|---|
| Musunuri Shankar | CEO | $0 | $4.4M | 2026-10-09 |
| Castillo Kirsten | Director | $22.8K | $122.2K | 2024-11-22 |
| Zhang Junge | Director | $100.1K | $0 | 2023-06-14 |
| Kumar Ramesh | Director | $0 | $79.3K | 2022-10-06 |
| Johnson-Greene Treerita Essalima | CFO | $25.8K | $0 | 2026-06-15 |
| Fernandes Prabhavathi | Director | $9.1K | $0 | 2024-11-26 |
Past buying clusters
A cluster is a run of purchases by three or more insiders. Returns are the stock's return minus its benchmark's (IWM for small companies, SPY otherwise), from the first open after the run became a cluster. Past results, not a forecast.
| Window | Insiders | Total | Score | 21 days vs benchmark | 63 days vs benchmark | 126 days vs benchmark | Status |
|---|---|---|---|---|---|---|---|
| 2019-11-18 → 2019-12-12 | 3 | $490.8K | 56 | +84.9% (+88.2% raw) | +13.4% (-25.7% raw) | -19.2% (-32.2% raw) | closed |
| 2016-12-01 → 2016-12-15 | 3 | $34.4K | 26 | – | – | – | closed |
Yahoo Finance data, delayed, loaded through this server. Informational only; not investment advice.